Results 291 to 300 of about 1,309,584 (346)

Global trends and research hotspots in pulmonary rehabilitation for chronic obstructive pulmonary disease: a bibliometric analysis (2011-2024). [PDF]

J Thorac Dis
Yuan Q, Zeng Z.
europepmc   +1 more source

The relationship between preoperative clinical, respiratory, and hemodynamic parameters and the surgical anatomical classification of thrombi in patients with chronic thromboembolic pulmonary hypertension. [PDF]

BMC Pulm Med
Turan B, Kocakaya D, Yildizeli SO, Akaslan D, Atas H, Cimsit C, Arikan H, Bekiroglu N, Ermerak NO, Mutlu B, Karakurt S, Yildizeli B.   +11 more
europepmc   +1 more source

New Insights: P.I.G in Preterm Infants With Isolated PDA and Severe Pulmonary Hypertension. [PDF]

Case Rep Pediatr
Fadel NB, Almoli E, de Nanassy J, Mashally S.   +3 more
europepmc   +1 more source

Atypical manifestation of pulmonary lymphatic perfusion syndrome treated with percutaneous lymphatic embolization. [PDF]

Respir Med Case Rep
Rezaee M, Loening AM, Rockson S, Hung M.
europepmc   +1 more source

Patient education and self-management in interstitial lung disease: why and what, now how? [PDF]

ERJ Open Res
Khor YH.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Proteomics in Pulmonary Medicine

Chest, 2006
Proteomics is the study of the entire protein complement of the genome (the proteome) in a biological system. Proteomic studies require a multidisciplinary approach and have only been practical with the convergence of technical and methodologic improvements including the following: advances in mass spectrometry and genomic sequencing that now permit ...
Russell P, Bowler, Misoo C, Ellison, Nichole, Reisdorph   +2 more
openaire   +2 more sources

Update in pulmonary medicine

Clinics in Podiatric Medicine and Surgery, 2002
Chronic inflammation in many pulmonary diseases, such as sarcoidosis and IPF, lead to end-stage lung disease and fibrosis. In other diseases, such as chronic thromboembolic disease and emphysema, long-term complications can result in pulmonary hypertension and cor pulmonale. Therapeutic options for end-stage lung disease are quite limited. One possible
Elizabeth A, Brown, Stephen P, Hoffmann
openaire   +2 more sources

Update in Pulmonary Medicine

Annals of Internal Medicine, 2006
Pulmonary diseases, including chronic lung disease and pneumonia, are the third leading cause of death in the United States.
openaire   +4 more sources

Update in Pulmonary Medicine

2013
Pulmonary disorders are common and important causes of morbidity and even mortality in adolescents. Conditions that are considered in this article include asthma, cystic fibrosis, and vocal cord dysfunction. Chronic and recurrent exacerbations may occur in youth with such disorders; therefore, they must adhere to potentially many pharmacologic agents ...
openaire   +2 more sources

Pulmonary medicine and palliative care

Best Practice & Research Clinical Obstetrics & Gynaecology, 2001
Gynaecological malignancies affect the respiratory system both directly and indirectly. Malignant pleural effusion is a poor prognostic factor: management options include repeated thoracentesis, chemical pleurodesis, symptomatic relief of dyspnoea with oxygen and morphine, and external drainage.
M, Tucakovic, R, Bascom, P B, Bascom
openaire   +2 more sources